OTCMBEVVF
Market cap778kUSD
Dec 24, Last price
0.00USD
1D
-34.82%
1Q
-62.00%
Jan 2017
-98.35%
IPO
-98.73%
Name
Bee Vectoring Technologies International Inc
Chart & Performance
P/E
—
P/S
1.86
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
14.80%
Rev. gr., 5y
%
Revenues
602k
+21.12%
Net income
-5m
L-5.22%
CFO
-1m
L-60.20%
Earnings
Feb 28, 2025
Profile
Bee Vectoring Technologies International Inc., an agriculture technology company, develops and provides natural commercial farming solutions. Its solutions include the Hive and Bees, an inoculum dispenser system; Vectorpak with Vectorite, a recipe of ingredients that allows bees to carry crop BVT-CR7 and other beneficial fungi or bacteria in their outbound flights to the crops; active ingredients, such as BVT-CR7, an organic strain of a natural occurring endophytic fungus; and pollen distribution systems. The company's patented bee vectoring technology uses commercially-reared bees to deliver targeted crop controls through the natural process of pollination. It provides natural pest and disease management solutions for various crops, such as strawberries, sunflowers, apples, tomatoes, canola crops, blueberries, and other crops. The company was founded in 2000 and is headquartered in Mississauga, Canada.
Valuation
Title CAD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2023‑09 | 2022‑09 | 2021‑09 | 2020‑09 | 2019‑09 | 2018‑09 | 2017‑09 | 2016‑09 | 2015‑09 | |
| Income | |||||||||
Revenues | 602 21.12% | 497 24.47% | |||||||
Cost of revenue | 3,886 | 4,811 | |||||||
Unusual Expense (Income) | |||||||||
NOPBT | (3,284) | (4,314) | |||||||
NOPBT Margin | |||||||||
Operating Taxes | 31 | ||||||||
Tax Rate | |||||||||
NOPAT | (3,284) | (4,345) | |||||||
Net income | (4,675) -5.22% | (4,932) 19.64% | |||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | 449 | 265 | |||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | 72 | 66 | |||||||
Long-term debt | 943 | 1,330 | |||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | 345 | (1,335) | |||||||
| Cash flow | |||||||||
Cash from operating activities | (1,152) | (2,895) | |||||||
CAPEX | (54) | (225) | |||||||
Cash from investing activities | (227) | (179) | |||||||
Cash from financing activities | 1,295 | 580 | |||||||
FCF | (2,537) | (4,670) | |||||||
| Balance | |||||||||
Cash | 670 | 2,730 | |||||||
Long term investments | |||||||||
Excess cash | 640 | 2,705 | |||||||
Stockholders' equity | (7,703) | (5,135) | |||||||
Invested Capital | 9,713 | 9,869 | |||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | 137,556 | 120,207 | |||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | (3,039) | (4,074) | |||||||
EV/EBITDA | |||||||||
Interest | 188 | 31 | |||||||
Interest/NOPBT | |||||||||